{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T02:38:16Z","timestamp":1783996696626,"version":"3.55.0"},"reference-count":97,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Ischemic heart disease (IHD) remains a major global health burden, highlighting the urgent need for early, non-invasive diagnostic biomarkers. MicroRNAs (miRNAs), small non-coding RNA molecules that regulate gene expression, have emerged as promising candidates due to their stability in circulation and involvement in cardiovascular processes. This systematic review aimed to evaluate the potential of specific miRNAs as early diagnostic biomarkers in IHD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Searches were performed in PubMed, Scopus, and Web of Science databases up to June 31, 2024. Eligible studies were selected based on predefined inclusion criteria. We identified recurrently dysregulated miRNAs and used miRTarBase to retrieve experimentally validated gene targets. Subsequently, gene set enrichment analysis (GSEA) was performed using Enrichr, referencing BioPlanet, KEGG, and Panther pathway libraries. Functional annotation was further explored using TAM 2.0.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 38 studies met the inclusion criteria. Among the reported miRNAs, miR-126, miR-21, miR-145, miR-92a, and miR-155 were the most frequently and consistently dysregulated across various IHD subtypes. Although expression patterns varied, these miRNAs were recurrently implicated in IHD-related processes. GSEA revealed enrichment of their gene targets in key pathways such as p53, TGF-\u03b2, and FoxO signaling, as well as in processes involving apoptosis and angiogenesis critical in vascular injury, remodeling, and immune activation. Several cancer-related pathways were also enriched, underscoring molecular overlaps between tumorigenesis and atherosclerosis. TAM 2.0 functional annotation supported these findings, linking the selected miRNAs to smooth muscle differentiation, cytokine signaling, and regulation by key transcription factors including SMAD4, STAT3, and AP-1.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our findings suggest that a panel combining the identified miRNAs may offer greater diagnostic value for IHD than individual markers, given their involvement in multiple IHD-related biological processes and pathways. The recurrent dysregulation of these miRNAs across diverse studies supports their potential as components of a robust, non-invasive diagnostic tool. However, expression variability and pathway overlap with other diseases, such as cancer, indicate the need for further validation. Larger prospective studies are warranted to validate their clinical applicability in IHD screening and risk stratification.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p>International Prospective Register of Systematic Reviews (PROSPERO), identifier CRD42024583265.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2025.1545023","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:27:33Z","timestamp":1755840453000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Circulating microRNAs as biomarkers for ischemic heart disease: a systematic review and gene set enrichment analysis"],"prefix":"10.3389","volume":"12","author":[{"given":"Yasmine","family":"Alcibahy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radwan","family":"Darwish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghena","family":"Abu-Sharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quinten","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Elgamassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.3390\/app14062581","article-title":"Morbidity and mortality trends of ischemic heart disease and medical interventions in mediterranean Countries\u2014Pre-COVID analysis: croatia, Slovenia, France, Italy, and Spain.","volume":"14","author":"Biloglav","year":"2024","journal-title":"Appl Sci."},{"key":"B2","year":"2010","journal-title":"Cardiovascular Disability: Updating the Social Security Listings."},{"key":"B3","doi-asserted-by":"publisher","first-page":"474","DOI":"10.4314\/ahs.v17i2.22","article-title":"Expression of miR-126 and its potential function in coronary artery disease.","volume":"17","author":"Wang","year":"2017","journal-title":"Afr Health Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2217\/bmm.10.60","article-title":"Clinical application of sensitive cardiac troponin assays: potential and limitations.","volume":"4","author":"Twerenbold","year":"2010","journal-title":"Biomark Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation.","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1093\/cvr\/cvw174","article-title":"Identifying circulating microRNAs as biomarkers of cardiovascular disease: a systematic review.","volume":"111","author":"Navickas","year":"2016","journal-title":"Cardiovasc Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.ncrna.2024.11.004","article-title":"The functions of immune system-derived miRNAs in cardiovascular diseases.","volume":"11","author":"Sufianov","year":"2025","journal-title":"Noncoding RNA Res"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5192","DOI":"10.3390\/ijms24065192","article-title":"miRNA dysregulation in cardiovascular diseases: current opinion and future perspectives.","volume":"24","author":"Sessa","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/978-1-60761-863-8_15","article-title":"The guideline of the design and validation of MiRNA mimics.","volume":"676","author":"Wang","year":"2011","journal-title":"Methods Mol Biol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019.","volume":"438","author":"Kr\u00fctzfeldt","year":"2005","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"68","DOI":"10.5596\/c14-016","article-title":"Product review: Covidence (systematic review software).","volume":"35","author":"Babineau","year":"2014","journal-title":"J Can Health Lib Assoc."},{"key":"B13","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","article-title":"miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions.","volume":"50","author":"Huang","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"B15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","article-title":"Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool.","volume":"14","author":"Chen","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"B16","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: a comprehensive gene set enrichment analysis web server 2016 update.","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e90","DOI":"10.1002\/cpz1.90","article-title":"Gene set knowledge discovery with enrichr.","volume":"1","author":"Xie","year":"2021","journal-title":"Curr Protoc"},{"key":"B18","doi-asserted-by":"publisher","first-page":"W180","DOI":"10.1093\/nar\/gky509","article-title":"TAM 2.0: tool for MicroRNA set analysis.","volume":"46","author":"Li","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5551\/jat.35923","article-title":"Potential role of lipometabolism-related MicroRNAs in peripheral blood mononuclear cells as biomarkers for coronary artery disease.","volume":"24","author":"Dong","year":"2017","journal-title":"J Atheroscler Thromb"},{"key":"B20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-023-01957-7","article-title":"Unlocking the potential of microRNAs: machine learning identifies key biomarkers for myocardial infarction diagnosis.","volume":"22","author":"Samadishadlou","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"962","DOI":"10.3390\/biom11070962","article-title":"Circulating extracellular miRNA analysis in patients with stable CAD and acute coronary syndromes.","volume":"11","author":"Zhelankin","year":"2021","journal-title":"Biomolecules"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e0216363","DOI":"10.1371\/journal.pone.0216363","article-title":"MiR-423 is differentially expressed in patients with stable and unstable coronary artery disease: a pilot study.","volume":"14","author":"Rizzacasa","year":"2019","journal-title":"PLoS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s11010-016-2805-z","article-title":"The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome.","volume":"422","author":"Darabi","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"B24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3390\/genes11020164","article-title":"Circulatory miR-133b and miR-21 as novel biomarkers in early prediction and diagnosis of coronary artery disease.","volume":"11","author":"Kumar","year":"2020","journal-title":"Genes"},{"key":"B25","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1007\/s11033-021-06352-7","article-title":"Identification of miR-17, miR-21, miR-27a, miR-106b and miR-222 as endoplasmic reticulum stress-related potential biomarkers in circulation of patients with atherosclerosis.","volume":"48","author":"Telkoparan-Akillilar","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B26","doi-asserted-by":"publisher","first-page":"9093151","DOI":"10.1155\/2020\/9093151","article-title":"Diagnostic role of plasma MicroRNA-21 in stable and unstable angina patients and association with aging.","volume":"2020","author":"Ali Sheikh","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.3390\/jpm13071161","article-title":"Evaluation of microRNA expression features in patients with various types of arterial damage: thoracic aortic aneurysm and coronary atherosclerosis.","volume":"13","author":"Ekedi","year":"2023","journal-title":"J Pers Med"},{"key":"B28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2018.08.031","article-title":"Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease.","volume":"275","author":"Hortmann","year":"2019","journal-title":"Int J Cardiol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"654","DOI":"10.3389\/fphys.2020.00654","article-title":"Serum exosomal MicroRNA-21, MicroRNA-126, and PTEN are novel biomarkers for diagnosis of acute coronary syndrome.","volume":"11","author":"Ling","year":"2020","journal-title":"Front Physiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s40291-022-00622-1","article-title":"Introducing circulating vasculature-related transcripts as biomarkers in coronary artery disease.","volume":"27","author":"Abdallah","year":"2023","journal-title":"Mol Diagn Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e11428","DOI":"10.1097\/MD.0000000000011428","article-title":"Circulating microRNA expression profiling and bioinformatics analysis of dysregulated microRNAs of patients with coronary artery disease.","volume":"97","author":"Zhong","year":"2018","journal-title":"Medicine"},{"key":"B32","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1093\/labmed\/lmac102","article-title":"Platelet MicroRNA-484 as a novel diagnostic biomarker for acute coronary syndrome.","volume":"54","author":"Masoodi Khabar","year":"2023","journal-title":"Lab Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1159\/000484236","article-title":"miR-126 in peripheral blood mononuclear cells negatively correlates with risk and severity and is associated with inflammatory cytokines as well as intercellular adhesion molecule-1 in patients with coronary artery disease.","volume":"139","author":"Wu","year":"2018","journal-title":"Cardiology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"532915","DOI":"10.4061\/2011\/532915","article-title":"MicroRNA expression profile in CAD patients and the impact of ACEI\/ARB.","volume":"2011","author":"Weber","year":"2011","journal-title":"Cardiol Res Pract"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e80345","DOI":"10.1371\/journal.pone.0080345","article-title":"Diagnostic potential of plasmatic MicroRNA signatures in stable and unstable angina.","volume":"8","author":"D\u2019Alessandra","year":"2013","journal-title":"PLoS One"},{"key":"B36","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1080\/1354750X.2018.1501760","article-title":"Circulating miRNA-33: a potential biomarker in patients with coronary artery disease.","volume":"24","author":"Reddy","year":"2019","journal-title":"Biomarkers"},{"key":"B37","first-page":"347","article-title":"Circulating microRNA-126 as an independent risk predictor of coronary artery disease: a case-control study.","volume":"32","author":"Ali","year":"2021","journal-title":"EJIFCC."},{"key":"B38","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1093\/icvts\/ivy058","article-title":"Circulating pro-angiogenic micro-ribonucleic acid in patients with coronary heart disease.","volume":"27","author":"Zhang","year":"2018","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B39","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/labmed\/lmad094","article-title":"Alteration of circulating miRNAs during myocardial infarction and association with lipid levels.","volume":"55","author":"Ozuynuk-Ertugrul","year":"2024","journal-title":"Lab Med"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.26655\/JMCHEMSCI.2023.5.22","article-title":"Role of MiRNA126 as a biomarker for coronary artery disease in iraqi patients.","volume":"6","author":"Taher","year":"2023","journal-title":"J Med Chem Sci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.1111\/jcmm.15001","article-title":"Circulating microRNA profiles based on direct S-Poly(T)Plus assay for detection of coronary heart disease.","volume":"24","author":"Su","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphys.2019.00123","article-title":"Circulating MiR-17-5p, MiR-126-5p and MiR-145-3p are novel biomarkers for diagnosis of acute myocardial infarction.","volume":"10","author":"Xue","year":"2019","journal-title":"Front Physiol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1161\/CIRCRESAHA.109.215566","article-title":"Circulating microRNAs in patients with coronary artery disease.","volume":"107","author":"Fichtlscherer","year":"2010","journal-title":"Circ Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1253\/circj.CJ-19-1181","article-title":"Circulating MicroRNA-423-3p improves the prediction of coronary artery disease in a general population - six-year follow-up results from the china-cardiovascular disease study.","volume":"84","author":"Wang","year":"2020","journal-title":"Circ J"},{"key":"B45","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3967\/bes2016.073","article-title":"Circulating MicroRNAs as novel diagnostic biomarkers for very early-onset (\u226440 years) coronary artery disease.","volume":"29","author":"Du","year":"2016","journal-title":"Biomed Environ Sci"},{"key":"B46","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/MCA.0000000000000088","article-title":"microRNA-155 is inversely associated with severity of coronary stenotic lesions calculated by the Gensini score.","volume":"25","author":"Zhu","year":"2014","journal-title":"Coron Artery Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"18438","DOI":"10.1038\/s41598-023-45146-8","article-title":"Peripheral blood mononuclear cells expression of miR-200c, miR-125b, miR-27b, miR-203, and miR-155 in patients with significant or insignificant coronary artery stenosis.","volume":"13","author":"Saadatian","year":"2023","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12920-019-0570-z","article-title":"Transcriptome sequencing of lncRNA, miRNA, mRNA and interaction network constructing in coronary heart disease.","volume":"12","author":"Liao","year":"2019","journal-title":"BMC Med Genomics"},{"key":"B49","doi-asserted-by":"publisher","first-page":"e0123477","DOI":"10.1371\/journal.pone.0123477","article-title":"Plasma Levels of microRNA-145 are associated with severity of coronary artery disease.","volume":"10","author":"Gao","year":"2015","journal-title":"PLoS One"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e001223","DOI":"10.1136\/openhrt-2019-001223","article-title":"MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability.","volume":"7","author":"Singh","year":"2020","journal-title":"Open Heart"},{"key":"B51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3892\/etm.2019.7555","article-title":"Plasma-derived exosomal miR-183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury.","volume":"18","author":"Zhao","year":"2019","journal-title":"Exp Ther Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/00365513.2018.1435904","article-title":"Alteration in microRNA-155 level correspond to severity of coronary heart disease.","volume":"78","author":"Qiu","year":"2018","journal-title":"Scand J Clin Lab Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.3892\/mmr.2016.5566","article-title":"miR-22-5p revealed as a potential biomarker involved in the acute phase of myocardial infarction via profiling of circulating microRNAs.","volume":"14","author":"Maciejak","year":"2016","journal-title":"Mol Med Rep"},{"key":"B54","doi-asserted-by":"publisher","first-page":"42916","DOI":"10.1038\/srep42916","article-title":"Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.","volume":"7","author":"Faccini","year":"2017","journal-title":"Sci Rep"},{"key":"B55","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1186\/s12872-022-02711-9","article-title":"Identification of a circulating microRNAs biomarker panel for non-invasive diagnosis of coronary artery disease: case-control study.","volume":"22","author":"Abdallah","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B56","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.4161\/cc.8.21.9837","article-title":"MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease.","volume":"8","author":"Zhang","year":"2009","journal-title":"Cell Cycle"},{"key":"B57","doi-asserted-by":"publisher","first-page":"6658","DOI":"10.1111\/jcmm.15316","article-title":"miR-145 inhibits the proliferation and migration of vascular smooth muscle cells by regulating autophagy.","volume":"24","author":"Wang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/iub.1751","article-title":"MicroRNA-21 drives the switch to a synthetic phenotype in human saphenous vein smooth muscle cells.","volume":"70","author":"Alshanwani","year":"2018","journal-title":"IUBMB Life"},{"key":"B59","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.devcel.2008.07.002","article-title":"The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis.","volume":"15","author":"Wang","year":"2008","journal-title":"Dev Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"117953","DOI":"10.1016\/j.biopha.2025.117953","article-title":"MicroRNA-126: from biology to therapeutics.","volume":"185","author":"Guo","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"B61","doi-asserted-by":"publisher","first-page":"7437281","DOI":"10.1155\/2022\/7437281","article-title":"miR-155: an important role in inflammation response.","volume":"2022","author":"Hu","year":"2022","journal-title":"J Immunol Res"},{"key":"B62","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.2147\/IJN.S138400","article-title":"Gold nanoparticle-based miR155 antagonist macrophage delivery restores the cardiac function in ovariectomized diabetic mouse model.","volume":"12","author":"Jia","year":"2017","journal-title":"Int J Nanomedicine"},{"key":"B63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/ncb2441","article-title":"Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs.","volume":"14","author":"Hergenreider","year":"2012","journal-title":"Nat Cell Biol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejim.2023.04.013","article-title":"High miR-126-3p levels associated with cardiovascular events in a general population.","volume":"113","author":"Martinez-Arroyo","year":"2023","journal-title":"Eur J Intern Med"},{"key":"B65","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1159\/000430214","article-title":"MicroRNA-21 negatively regulates Treg cells through a TGF-\u03b21\/Smad-independent pathway in patients with coronary heart disease.","volume":"37","author":"Li","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1038\/cdd.2009.153","article-title":"The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease.","volume":"16","author":"Elia","year":"2009","journal-title":"Cell Death Differ"},{"key":"B67","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/gcc.10316","article-title":"High expression of precursor microRNA-155\/BIC RNA in children with Burkitt lymphoma.","volume":"39","author":"Metzler","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"B68","doi-asserted-by":"publisher","first-page":"724209","DOI":"10.1155\/2014\/724209","article-title":"The clinicopathological significance of microRNA-155 in breast cancer: a meta-analysis.","volume":"2014","author":"Zeng","year":"2014","journal-title":"Biomed Res Int"},{"key":"B69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clineuro.2018.12.005","article-title":"Prognostic role of microRNA-155 expression in gliomas: a meta-analysis.","volume":"176","author":"Zhou","year":"2019","journal-title":"Clin Neurol Neurosurg"},{"key":"B70","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/s0008-6363(97)00113-2","article-title":"Interactive effect of the p53 gene and cigarette smoking on coronary artery disease.","volume":"35","author":"Wang","year":"1997","journal-title":"Cardiovasc Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s44161-022-00206-6","article-title":"TP53- mediated clonal hematopoiesis confers increased risk for incident atherosclerotic disease.","volume":"2","author":"Zekavat","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"B72","doi-asserted-by":"publisher","first-page":"6984","DOI":"10.12659\/MSM.910763","article-title":"Relationship of autophagy and apoptosis with total occlusion of coronary arteries.","volume":"24","author":"Kaplan","year":"2018","journal-title":"Med Sci Monit"},{"key":"B73","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1096\/fj.201800975RRR","article-title":"SCAP knockdown in vascular smooth muscle cells alleviates atherosclerosis plaque formation via up-regulating autophagy in ApoE-\/- mice.","volume":"33","author":"Li","year":"2019","journal-title":"FASEB J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"e55477","DOI":"10.1371\/journal.pone.0055477","article-title":"Soluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarction.","volume":"8","author":"Nilsson","year":"2013","journal-title":"PLoS One"},{"key":"B75","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jacc.2010.08.628","article-title":"Serum caspase-3 p17 fragment is elevated in patients with ST-segment elevation myocardial infarction: a novel observation.","volume":"57","author":"Agosto","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B76","first-page":"15147","article-title":"B-cell lymphoma 2 rs17757541 C>G polymorphism was associated with an increased risk of coronary artery disease in a Chinese population.","volume":"8","author":"Xuan","year":"2015","journal-title":"Int J Clin Exp Pathol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.redox.2017.05.027","article-title":"SIRT1 inhibition causes oxidative stress and inflammation in patients with coronary artery disease.","volume":"13","author":"Chan","year":"2017","journal-title":"Redox Biol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1007\/s12013-014-0257-1","article-title":"Reduced apoptosis after acute myocardial infarction by simvastatin.","volume":"71","author":"Luo","year":"2015","journal-title":"Cell Biochem Biophys"},{"key":"B79","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.tibs.2004.03.008","article-title":"New insights into TGF-beta-Smad signalling.","volume":"29","author":"ten Dijke","year":"2004","journal-title":"Trends Biochem Sci."},{"key":"B80","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/01.hyp.28.5.881","article-title":"Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-T\u00e9moin de l\u2019Infarctus du Myocarde (ECTIM) Study.","volume":"28","author":"Cambien","year":"1996","journal-title":"Hypertension"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.ATV.0000217747.66517.11","article-title":"Association of transforming growth factor-beta1 gene polymorphisms with myocardial infarction in patients with angiographically proven coronary heart disease.","volume":"26","author":"Koch","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.cellsig.2015.09.003","article-title":"VCAM-1 is a TGF-\u03b21 inducible gene upregulated in idiopathic pulmonary fibrosis.","volume":"27","author":"Agassandian","year":"2015","journal-title":"Cell Signal"},{"key":"B83","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/0167-5699(89)90136-9","article-title":"Inflammatory and immunomodulatory roles of TGF-beta.","volume":"10","author":"Wahl","year":"1989","journal-title":"Immunol Today"},{"key":"B84","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1006\/jmcc.1999.0999","article-title":"The expression of TGF-beta receptors in human atherosclerosis: evidence for acquired resistance to apoptosis due to receptor imbalance.","volume":"31","author":"McCaffrey","year":"1999","journal-title":"J Mol Cell Cardiol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3389\/fphys.2017.00108","article-title":"TGF-\u03b21 Gene -509C\/T polymorphism and coronary artery disease: an updated meta-analysis involving 11,701 subjects.","volume":"8","author":"Li","year":"2017","journal-title":"Front Physiol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biopha.2018.05.068","article-title":"MiR-155 inhibits transformation of macrophages into foam cells via regulating CEH expression.","volume":"104","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"B87","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40001-020-00403-8","article-title":"MicroRNA-145 is involved in endothelial cell dysfunction and acts as a promising biomarker of acute coronary syndrome.","volume":"25","author":"Wu","year":"2020","journal-title":"Eur J Med Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yjmcc.2018.09.004","article-title":"MicroRNA-23a-5p promotes atherosclerotic plaque progression and vulnerability by repressing ATP-binding cassette transporter A1\/G1 in macrophages.","volume":"123","author":"Yang","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9001","DOI":"10.3390\/ijms23169001","article-title":"miRNA in ischemic heart disease and its potential as biomarkers: a comprehensive review.","volume":"23","author":"Kong","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B90","doi-asserted-by":"publisher","first-page":"19640","DOI":"10.1002\/jcp.28564","article-title":"Activation of the STAT3\/microRNA-21 pathway participates in angiotensin II-induced angiogenesis.","volume":"234","author":"Chen","year":"2019","journal-title":"J Cell Physiol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e18049","DOI":"10.1097\/MD.0000000000018049","article-title":"The relationship of MicroRNA-21 and plaque stability in acute coronary syndrome.","volume":"98","author":"He","year":"2019","journal-title":"Medicine"},{"key":"B92","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7150\/ijms.4514","article-title":"MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis.","volume":"9","author":"Qin","year":"2012","journal-title":"Int J Med Sci"},{"key":"B93","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1536\/ihj.15-293","article-title":"MicroRNA-214 inhibits left ventricular remodeling in an acute myocardial infarction rat model by suppressing cellular apoptosis via the phosphatase and tensin homolog (PTEN).","volume":"57","author":"Yang","year":"2016","journal-title":"Int Heart J"},{"key":"B94","doi-asserted-by":"publisher","first-page":"e000946","DOI":"10.1161\/JAHA.114.000946","article-title":"Single intracoronary injection of encapsulated antagomir-92a promotes angiogenesis and prevents adverse infarct remodeling.","volume":"3","author":"Bellera","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/aps.2018.30","article-title":"miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.","volume":"39","author":"Zhou","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1021\/acsbiomaterials.1c01198","article-title":"Nanoparticle-Delivered microRNA-153-3p alleviates myocardial infarction-induced myocardial injury in a rat model.","volume":"8","author":"Zhou","year":"2022","journal-title":"ACS Biomater Sci Eng"},{"key":"B97","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1007\/s12265-022-10216-1","article-title":"Modified Exosomes: a Good Transporter for miRNAs within stem cells to treat ischemic heart disease.","volume":"15","author":"Chen","year":"2022","journal-title":"J Cardiovasc Transl Res"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1545023\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T05:27:37Z","timestamp":1755840457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2025.1545023\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":97,"alternative-id":["10.3389\/fmed.2025.1545023"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2025.1545023","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"article-number":"1545023"}}